SpringerProtocols: Abstract: Preclinical Behavioral Approaches to the Identification and Study of Antipsychotic Drug Action and Schizophrenia

Preclinical Behavioral Approaches to the Identification and Study of Antipsychotic Drug Action and Schizophrenia

By: Sheena A. Josselyn³, Franco J. Vaccarino³

Abstract

Full Text

Download PDF (3276K)

Schizophrenia is a group of illnesses of unknown origin with a yearly prevalence of 0.4–0.8% in the general population (Dohrenwend, 1980). Schizophrenia is characterized by a spectrum of symptoms that are commonly grouped into positive (including hallucinations, incoherence, delusions, distorted thought, and incongruity of affect) and negative (including poverty of speech, flat affect, low social drive, curbing of interest, and diminished sense of purpose) categories (Crow, 1980; Berrios, 1985; Kane, 1993a).

Affiliation(s): (3) Clarke Institute of Psychiatry, Ontarto, Canada

Book Title: In Vivo Neuromethods

Series: Neuromethods | Volume: 32 | Pub. Date: Oct-24-1997 | Page Range: 177-225 | DOI: 10.1385/0-89603-511-5:177

Subject: Neuroscience

References

Download References

Ahlenius, S and Engel, J (1977) Potentiation by alpha-methyltyrosine of the suppression of food-reinforced lever-pressing behavior induced by antipsychotic drugs Acta Pharmacol Toxicol 40, 115–125

Ahtee, L. and Shilhto, E. (1970) The effect of benzodiazepines and atropine on exploratory behavior and motor activity in mice Br J Pharmacol 40, 361–371

Anderson, J. J, Kask, A M, and Chase, T N. (1996) Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists Eur J Pharmacol 295, 163–168.

Anisman, H., Corradini, A., Tombaugh, T. N, and Zacharko, R M (1982a) Avoidance performance, cue and response-choice discrimination after neuroleptic treatment Pharmacol Biochem Behav 17, 1245–1249

Anisman, H, Irwin J, Zacharko R M, and Tombaugh T N (1982b) Effects of dopamine receptor blockade on avoidance performance assessment of effects on cue-shock and response-outcome associations. Behav Neural Biol 36, 280–290

Archer, T, Ogren, S O, and Ross, S B. (1982) Serotonin involvement in aversive conditioning reversal of the fear retention deficit by long-term pchloroamphetamine but not p-chlorophenylalanine Neurosci Lett 34, 75–82

Arnt, J (1982) Pharmacological specificity of conditioned avoidance response inhibition in rats inhibition by neuroleptics and correlation to dopamine receptor blockade Acta Pharmacol Toxicol 51, 321–329

Arnt, J. and Hytell, J (1985) Differential involvement of dopamine Dl and D2 receptors in the circling behavior induced by apomorphine, SK&F 38393, pergolide and LY 17155 in 6-hydroxydopamine-lesioned rats Psychopharmacology 85, 346–352

Arnt, J., Hytell, J, and Perregaard, J (1987) Dopamine Dl receptor agonists combined with the selective D2 agonist quinpirole facilitate the expression of oral stereotyped behavior in rats Eur J Pharmacol 133, 137–145.

Arnt, J., Scheel-Kruger, J, Magelund, G, and Krogsgaard-Larsen, P (1979) Muscimol and related GABA receptor agonists the potency of GABAergic drugs in vivo determined after intranigral injection J Pharm Pharmacol 31, 306–313

Bakshi, V P, Swerdlow, N. R., and Geyer, M A. (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response J Pharm Exp Ther 271, 787–794

Baldessarini, R. J. and Tarsy, D. (1976) Mechanisms underlying tardive dyski nesia Res Pub Ass Res Nervous Mental Dis 55, 433–436

Baldessarini, R J, Cohen, B M and Teicher, M N, (1990) Pharmacologic treatment, in Schizophrenia Treatment of Acute Psychotic Episodes, (Levy, S T and Ninan, P T, eds ), American Psychiatric Press, Washington, DC, pp 61–118.

Baldwin, D S. and Montgomery, S A (1995) First clinical experience with olanzapine (LY 170053) results of an open-label safety and dose-rangmg study in patients with schizophrenia. Int. Clin. Psychopharmacology 10, 239–244.

Barghon, R, Protais, P, Colboc, O., and Costentin, J. (1981) Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics Neurosci. Lett 27, 69–73

Bartholini, G, Haefely, W, Jalfre, M, Keller, H H, and Pletscher, A (1972) Effects of clozapine on cerebral catecholaminergic neurons systems. Br J Pharmacol 46, 736–740

Beasley, C M, Tollefson, G, Tran, P, Satterlee, W, Sanger, T, Hamilton, S, and the Olanzapine HGAD Study Group (1996) Olanzapine versus placebo and haloperidol acute phase results of the North American double-blind olanzapine trial Neuropsychopharmacology 14, 111–123

Bemnger, R J (1983) The role of dopamine in locomotor activity and learning Brain Res Rev 6, 173–196

Bemnger, R J (1988) The slow therapeutic action of antipsychotic drugs, in Animal Models of Psychiatric Disorder Selected Models of Anxiety, Depression and Psychosis, (Simon, P, Soubrie P, and Wildlocher, D., eds ), Karger, Basel, pp 36–51

Beninger, R J (1989) Dissociating the effects of altered dopaminergic function on performance and learning Brain Res Bull 23, 365–371

Bemnger, R J (1993) Role of Dl and D2 receptors in learning, in Dl D2 Dopamine Receptor Interactions, (Waddington, J L., ed ), Academic, London, pp 115–157

Beninger, R J and Hahn, B L (1983) Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning Science 220, 1304–1306

Beninger, R J. and Herz, R S (1986) Pimozide blocks establishment but not expression of cocame-produced environment-specific conditioning Life Set 38, 1425–1431

Beninger, R J, Cheng, M, Hahn, B L, Hoffman, D C, Mazurksi, E J, Morency, M A, Ramm, P, and Stewart, R J (1987) Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding in rats Psychopharmacology 92, 343–349

Beninger, R J, Hoffman, D C, and Mazurksi, E J (1989) Receptor subtypespecific dopaminergic agents and conditioned behavior Neurosci Biobehav Rev 13, 113–122

Beninger, R J, Mason, S T, Phillips A G and Fibiger, H C (1980) The use of extinction to investigate the nature of neuroleptic-mduced avoidance deficits Psychopharmacology 69, 11–18

Berrios, G E (1985) Positive and negative symptoms and Jackson A concep tual history Arch Gen Psychiat 42, 95–97

Biggio, G, Casu, M, Corda, M G, Vernaleone, F, and Gessa, G L (1977) Effect of muscimol, a GABA-mimetic agent, on dopamine metabolism in the mouse brain Life Sci 21, 525–532

Bolino, F, Di Michele, V, Di Cicco, L, Manna, V, Daneluzzo, E, and Casacchia, M (1994) Sensorimotor gating and habituation evoked by electro-cutaneous stimulation in schizophrenia Bio Psychiat 36, 670–679

Borenstein, P. and Bles, G (1965) Effects cliniques et electroencephalographiques du metoclopramide en psychiatrie Therapie 20, 975–995

Borison, R L, Arvamtis, L A, and Miller, B G (1996) ICI 204, 636, an atypical antipsychotic efficacy and safety in a multicenter, placebo-controlled trial m patients with schizophrenia J Clin Psychopharmacol 16, 158–169

Boyce, S, Kelly, E, Davis, A, Fleminger, S, Jenner, P, and Marsden, C D (1985) SCH 23390 may alter dopamine-mediated motor behavior via striatal Dl receptors Biochem Pharmacol 34, 1665–1669

Bracha, H S (1987) Abnormal rotation (circling) behavior a dopamine related asymmetry Preliminary findings in unmedicated and never-medicated schizophrenic patients. Biol Psychiat. 22, 995–1003

Bracha, H S, Livingston, R L, Clothier, J, Linington, B B, and Karson, C N (1993) Correlation of seventy of psychiatric patients’ delusions with right hemispatial inattention (left turning behavior) Am J Psychiat 150, 330–334

Braff, D L (1993) Information processing and attention dysfunctions in schizophrenia Schiz Bull 19, 233–259

Braff, D L and Geyer, M A (1990) Sensorimotor gating and schizophrenia human and animal studies Arch. Gen Psychiat 47, 181–188

Braff, D. L, Grillon, C and Geyer, M. A. (1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiat 49, 206–215.

Braff, D L, Stone, C, Callaway, E, Geyer, M A, Glick, I D and Bah, L (1978) Prestimulus effects of human startle reflex in normals and schizophrenics Psychophys 15, 339–343

Brier, A, Buchanan, R W, Kirkpatrick, B, Davis, O R, Irish, D, Summerfelt, A, and Carpenter, W T (1994) Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiat 151, 20–26

Britton, D R, Curzon, P., Yahiro, L., Buckley, M, Tufano, M, and Nadzan, A (1992) Evaluation of a stable CCK agonist (A68552) in conditioned avoidance responding in mice, rats, and primates comparison with typical and atypical antipsychotics Pharmacol Biochem Behav 43, 69–376

Brown, H (1972) Possible anticholinesterase-like effects of trans(-) 8 and-9 tetrahydrocannabinol as observed in the general motor activity of mice Psychopharmacology 27, 111–116

Buchsbaum, M S, DeLisi, L E, and Holcomb, H H. (1984) Anterioposterior gradients in cerebral glucose use in schizophrenia and affective disorders Arch Gen Psychiat 41, 1159–1166

Bunney, B G, Bunney, W E, and Carlsson, A (1995) Schizophrenia and glutamate, in Psychopharmacology The Fourth Generation of Progress, (Bloom, F E, and Kupfer D J, eds ), Raven, New York, pp 1205–1214

Burki, H. R, Eichenberger, E, Bayers, A C, and White, T G (1975) Clozapine and the dopamine hypothesis of schizophrenia, a critical appraisal Pharmacopsychiatia 8, 115–121

Busber, M and Koch, M (1994) Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex Psychopharmacology 113, 487–492

Cadenhead, K and Braff, D L (1992) Which criteria select “psychosis-prone” individuals? Bio Psychiat 31, 161A–162A

Cadenhead, K S, Geyer, M A, and Braff, D L (1993) Impaired startle prepulse inhibition and habituation in schizotypal patients Am J Psychiat 150, 1862–1867

Caine, S B, Geyer, M A, and Swerdlow, N R (1995) Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle m the rat Neuropsychopharmacol 12, 139–145

Campbell, A, Herschel, M, Cohen, B M., and Baldessanm, R J (1980) Tissue levels of haloperidol by radioreceptor assay and behavioral effects of haloperidol in the rat Life Sci 27, 633–640

Cannon, J G and Lippa, A S (1977) Effects of clozapine, chlorpromazine and diazepam upon adjunctive and schedule controlled behaviors Pharmacol Biochem Behav 6, 581–587

Carlsson, M and Carlsson, A (1990) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice J Neural Transm 75, 221–226

Casey, D E (1980) Clozapine neuroleptic-induced EPS and tardive dyskinesia Psychopharmacology 99(suppl), S47–S53

Cassella, J V and Davis, M (1986) The design and calibration of a startle measurement system Physiol Behav 36, 377–383

Choinard, G, Jones, B, Remington, G et al (1993) A Canadian placebocontrolled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 13, 25–40.

Chouinard, G (1990) A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation Acta Psych Scand 359, 111–119

Chouinard, G (1995) Effects of risperidone in tardive dyskinesia an analysis of the Canadian multicenter risperidone study J Clin Psychopharmacol 15, 36S–44S

Chouinard, G, Vainer, J L, Belanger, M C, Turnier, L, Beaudry, P Boyk, J Y, and Miller, R (1994) Risperidone and clozapine in the treatment of drugresistant schizophrenia and neuroleptic-induced supersensitivity in psychosis Prog Neuro-Psychopharmacol Bio Psychi 18, 1129–1141

Christensen, A V, Amt, J, Hytell, J, and Svendsen, O (1984) Behavioural correlates to the dopamine Dl and D2 antagonists. Pol J Pharmacol. Pharm 36, 249–264

Claghorn, J, Honigfeld, G, Abuzzahab, F S, Wang, R, Steinbook, R, Tuason, V, and Klerman, G (1987) The risks and benefits of clozapine versus chlorpromazine J Chn Psychopharmacol 7, 377–384

Claus, A, Bollen, J, De Cuyper, H, Eneman, M, Malfroid, M, Peuskens, J, and Heylen, S (1992) Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients a multicentre double-blind comparative study Acta Psychia Scand 85, 295–305

Cole, J C and Rodgers, R J (1995) Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behavior of mice in the elevated plus-maze Pharmacol Bwchem Behav 52, 473–478

Cook, L and Davidson, A B (1978) Behavioral pharmacology animal models involving aversive control of behavior, in Psychopharmacology A Generation of Progress, (Lipton, M A, Di Mascio, A and Killam, K F, eds ), Raven, New York, pp 563–567

Cools, A R, Prinssen, E, and Ellenbroek, B A (1992) Interaction between aminergic systems in mesolimbic structures the importance of 5-HT2, D2 and Dl receptors in the olfactory tubercle for the atypical profile of neuroleptics Chn Neuropharmacol 15(suppl 1), 618A–619A

Cools, A R, Prinssen, E P M, and Ellenbroek, B A (1995) The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test effect of risperidone, prothipendyl, ORG 522, sertindole and olanzapine Psychopharmacology 119, 428–439

Corbett, R, Camacho, F, Woods, A T, Kerman, L L, Fishkin, R J, Brooks, K, and Dunn, R W (1995) Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors Psychopharmacology 120, 67–74

Corbett, R, Hartman, H, Kerman, L L, Woods, A T, Strupczewski, J T, Helsley, G C, Conway, P C, and Dunn, R W (1993) Effects of atypical antipsychotic agents on social behavior in rodents. Pharmacol Btochem Behav 45, 9–17

Costall, B and Naylor, R J (1973) Neuroleptic and non-neuroleptic catalepsy Arzneimittelforschung 23, 674–683

Costall, B and Naylor, R J (1974) On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity Psychopharmacology 34, 233–241

Costall, B and Naylor, R J (1974). Mesolimbic involvement with behavioral effects indicating antipsychotic activity Eur J Pharmacol 27, 46–58

Costall, B and Naylor, R J (1975) Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine. Psychopharmacology 43, 69–74

Costall, B and Naylor, R J (1976) A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonize the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems Eur J Pharmacol 40, 9–19

Courvoisier, S, Fournel, J, Ducrot, R, Kolsky, M, and Koetschet, P (1953) Proprieties pharmacodynamique du chlorhydrate de chloro-3(di-methylamino-3-propyl)-10 phenothiazine Arch Int Pharmacodyn Ther. 92, 305–361

Cowan, A, Dettmar, P. W, and Walter, D. S. (1975) The effects of buprenorphine, morphine and pentazocine on turning behaviour and stereotypy induced by apomorphine in the rat J Pharm Pharmacol 27, 15P

Creese, I, Burt, D R, and Snyder, S (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs Science 192, 481–483

Crow, T (1980) Molecular pathology of schizophrenia more than one disease process? Br Med J 280, 66–68

Davidson, A B and Weidley, E (1976) Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats Life Sci 18, 1279–1284

De Maio, D (1972) Clozapine, a novel major tranquilizer Clinical experiences and pharmacotherapeutic hypothesis. Arzneimittelforsch 22, 919–923

De Ryck, M, Schallert, T, and Teitelbaum, T (1980) Morphine versus haloperidol catalepsy in the rat a behavioral analysis of postural support mechanisms. Brain Res 201, 143–158

Delay, J and Deniker, O (1957) Caractenstiques psychologiques des medicaments neurleptiques, in Psychotropic Drugs, (Garattini, S. and Ghetti, V, eds ), Elsevier, Amsterdam, pp 485–501

Dixon, A K, Huber, C, and Lowe, D A (1994) Clozapine promotes approachoriented behavior in male mice J Clm Psychiatry 55(suppl B), 4–7

Ellenbroek, B A (1993) Treatment of schizophrenia, a clinical and preclinical evaluation of neuroleptic drugs Pharmacol. Ther 56, 1–78

Ellenbroek, B A., Lubbers, L J, and Cools, A R (1996) Activity of “Seroquel” (ICI204, 636) in animal models for atypical properties of antipsychotics a comparison with clozapine Neuropsychpharmacology 15, 406–416.

Ellenbroek, B A, Peeters, B, Honig, W M., and Cools, A. R (1987) The paw test a behavioral paradigm for differentiating between classical and atypical neuroleptic drugs Psychopharmacology 93, 343–348

Ellenbroek, B and Cools, A (1988) The paw test an animal model for neuroleptic drugs which fulfills the criteria for pharmacological isomorphism Life Set 42, 1205–1213.

Faustman, W. O. and Fowler, S. C. (1982) An examination of methodological refinements, clozapine and fluphenazine in the anhedonia paradigm Pharmacol Biochem Behav 17, 987–993

Faustman, W., Fowler, S, and Walker, C (1982) Time course of chronic haloperidol and clozapine upon operant rate and duration Eur J Pharmacol 70, 65–70

Fenton, H. M and Liebman, J M (1982) Self-stimulation response decrement patterns differentiate clonidme, baclofen, and dopamine antagonists from drugs causing performance deficit. Pharmacol Biochem Behav 17, 1207–1212

Fenton, H M, Hall, N R, and Liebman, J M (1982) Intracranial self-stimulation response decrement patterns differentiate drug-mduced performance deficits from effects on reward Soc Neurosa Abstr 8, 468

Fenton, H M, Leszczak, E, Gerhardt, S, and Liebman, J M (1984) Evidence for heterogeneous rotational responsiveness to apomorphine, 3-PPP and SKF 38393 in 6-hydroxydopamine-denervated rats Eur J Pharmacol 106, 363–372

Ferrari, F and Giuliani, D (1995) Behavioural assessment in rats of the antipsychotic potential of the potent dopamine D2 receptor antagonist, (-)eticlopride Pharmacol Rev 31, 261–267

Fibiger, H C, Zis, A P, and Phillips, A G (1975) Haloperidol-induced disruption of conditioned avoidance responding attenuation by prior training or by anticholinergic drugs Eur J Pharmacol 30, 309–314

Finger, F W (1972) Measuring behavioral activity, in Methods in Psychobiology, (Meyers, R D, ed.). Academic, New York, pp 1–21.

Fog, R (1967) Role of the corpus striatum in typical behavioral effects in rats produced by both amphetamine and neuroleptic drugs Acta Pharmacol Toxicol 25, 59–65

Fog, R (1972) On stereotypy and catalepsy studies on the effects of amphetamines and neuroleptics in rats Acta Neurol Scand 50, 1–9

Fontana D, Post, R M, Weiss, S R B, and Pert, A (1993) The role of Dl and D2 dopamine receptors in the acquisition and expression of cocaine-induced conditioned increases in locomotor behavior Behav Pharmacol 4, 375–387

Founezos, G and Wise, R A (1976) Pimozide-mduced extinction of intracranial self-stimulation response patterns rule out motor or performance deficits Brain Res 103, 377–380

Founezos, G, Hanson, P, and Wise, R A (1978) Neuroleptic-induced attenuation of brain stimulation reward in rats J Camp Physiol Psychol 92, 661–671

Fuxe, K, Anderson, K, Ogren, S O, Perez de la Mora, M, Schwartz, R, Hokfelt, T, Eneroth, P, Gustafsson, J A, and Skett, P (1979) GABA neurons and their interaction with monoamine neurons an anatomical, pharmacological and functional analysis, in GABA-Neurotransmitters, (Krogsgaard-Larsen, P, Scheel-Kruger, J, and Kofod, H, eds ), Munksgaard, Copenhagen, pp 74–94

Gallistel, C R and Davis, A J (1983) Affinity for the dopamine D2 receptor predicts neuroleptic potency in blocking the reinforcing effect of MFB stimulation Pharmacol Biochem Behav 20, 73–77

Gerber, G J, Sing, J, and Wise, R. A (1981) Pimozide attenuates lever pressing for water reinforcement in rats Pharmacol Biochem Behav 14, 201–205

Gerhardt, S and Liebman, J M (1981) Differential effects of drug treatments on nose-poke and bar-press self-stimulation Pharmacol Biochem Behav 15, 767–771

Gerlach, J (1991) New antipsychotics classification, efficacy and adverse effects Schiz Bull 17, 289–309

Gerlach, J. and Casey, D E (1988) Tardive dyskinesia Acta Psychiat Scand 77, 369–378

Gessler, S., Cutting J, Frith, C D, and Weinman, J (1989) Schizophrenic inability to judge facial emotion a controlled study Br J Clin Psychol 28, 19–29

Geyer, M A, Swerdlow, N R., Mansbach, R S, and Braff, D L (1990) Startle response models of sensorimotor gating and habituation deficits in schizophrenia Brain Res Bull 24, 485–498

Geyer, M A, Wilkinson, L S., Humby, T, and Robbins, T W (1993) Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia Biol Psychtat 34, 361–372

Graham, F (1975) The more or less startling effects of weak prestimuli Psychophysiology 12, 238–248

Grant E C (1968) An ethological description of non-verbal behaviour during interviews Br J Med Psychol 41, 172–184

Grillon, C, Ameli, R, Charney, D. S, Krystal, J, and Braff, D. (1992) Startle gating deficits occur across prepulse intensities in schizophrenic patients Biol Psychiatry 32, 939–943

Guy, A P and Gardner, C R (1985) Pharmacological characterization of a modifiedsocial interaction model of anxiety in the rat Neuropsychobiology 13, 194–200

Haefely, W, Kulcsar, A, Mohler, H, Pieri, L, Pole, P, and Schaffner, R. (1975) Possible involvement of GABA in the central actions of benzodiazepines, in Mechanisms of Action of Benzodiazepines, (Costa, E and Greengard, P, eds ), Raven, New York, pp 131–151

Handley, S L and Thomas, K V (1978) Influence of catecholamines on dexamphetamine-induced changes in locomotor activity Psychopharmacology 58, 283–288

Hirose, K, Matsushita, A, Eigyo, M, Jyoyama, H, Fujita, A, Tsukmoki, Y, Shiomi, T, and Matsubara, K (1981) Pharmacology of 2-0-chlorobenzoyl-4-chloro-N-methyl-N-glyglyglycinanilide hydrate (45-0088-S), a compound with benzodiazepine-like properties Arznetm Forsch 31, 63–69

Hoffman, D C (1994) The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-mduced place conditioning in rats Pharmacol Biochem Behav 47, 907–912

Hoffman, D C and Donavon, H (1994) Dl and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia Psychopharmacology 115, 447–453

Hoffman, D C and Donavon, H (1991) Does the atypical antipsychotic clozapine block the rewarding properties of amphetamine? Soc Neurosci Abstr 17, 686

Hoffman, D C and Donavan, H (1995) Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability. Psychopharmacology 120, 128–133

Hoffman, D C, Donavan, H, and Cassella, J V (1993) The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801 Psychopharmacology 111, 339–344

Hoffman, H. S and Ison, J R (1980) Reflex modification in the domain of startle I Some empirical findings and their implications for how the nervous system processes sensory input Psychol Rev 87, 175–189

Hoffman, H S and Searle, J L (1968) Acoustic and temporal factors in the evocation of startle. J Acoustic Soc America 43, 269–282

Janssen, P A. J and van Bever, W. F M (1978) Structure-activity relationships of the butyrophenones and diphenylbutylpiperidines, in Neuroleptics and Schizophrenia, (Iversen, L L, Iversen, S D., Snyder, S, H., eds ), Raven, New York, pp 1–35

Janssen, P A. J, Neimegeers, C. J E, and Schellekens, K. H L (1965) Is it possible to predict the clinical effects of neuroleptic drugs (major tranquihzers) from animal data? Part I Neuroleptic activity spectra for rats Arzneimittelforsch 15, 104–117

Janssen, P A J, Niemegeers, C J C, and Jageneau, A H M (1960) Apomorphine-antagonism in rats Arzneim Forsch 10, 1003–1005

Janssen, P A J, Niemegeers, C J E, Awouters, F, Schellekens, K H L, Megens, A H P, and Meert, T F (1988) Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties J Pharmacol Exp Ther 244, 685–693

Janssen, P, Niemegeers, C, and Schellekens, K (1966) Is it possible to predict the clinical effects of neuroleptic drugs (kajor tranquilizers) for animal data? Part III The subcutaneous and oral activity in rats and dogs of 56 neuroleptic drugs in the jumping box test Arzneim Forsch 16, 339–346

Javitt, D C (1987) Negative symptomatology and the PCP (phencyclidine) model of schizophrenia Hillside J Clin Psychiatry 9, 12–35

Javitt, D C. and Zukin, S R (1991) Recent advances in the phencyclidine model of schizophrenia Am J Psychiatry 148, 1301–1308

Jenner, P. and Marsden, C D (1986) Is the dopamine hypothesis of tardive dyskinesia completely wrong? Trends Neurosci 9, 259–261

Johansson, C, Jackson, D M, and Svensson, L (1994) The atypical antipsychotic, remoxipnde, blocks phencyclidine-induced disruption of prepulse inhibition in the rat Psychopharmacology 116, 437–442

Josselyn, S A, Miller, R, and Bemnger, R J Effects of clozapine and dopamine receptor subtypes a behavioral review Neurosci Biobeh Rev (in press)

Josselyn, S A and Bemnger, R J (1993) Neuropeptide Y intraaccumbens injections produce a place preference that is blocked by cis-flupenthixol Pharmacol Biochem Behav 46, 543–552

Josselyn, S A and Vaccarino, F J (1993) Effects of clozapine and cis-flupenthixol on the development and expression of conditioned activity Soc Neuro Abst 19, 382

Josselyn, S A, Franco, V P, and Vaccarino, F J (1996) Devazepide, a CCK_A antagonist, impairs the acquisition of conditioned reward and conditioned activity Psychopharmacology 123, 131–143

Joyce, E M (1988) The amphetamine model of schizophrenia a critique Amm Models Psychiatr Disord 2, 89–100

Juul Povlsen, U, Noring, U, Fog, R, and Gerlach, J (1985) Tolerability and therapeutic effect of clozapine A retrospective investigation of 216 patients treated with clozapine for up to 12 years Acta Psych Scand 71, 176–185

Kaempf, G L and Porter, J H (1987) Differential effects of pimozide and clozapine on schedule-controlled and scheduled-induced behaviors after acute and chronic administration J Pharmacol Exp Ther 243, 437–445

Kane, J M. (1993) Understanding and treating psychoses advances in research and therapy J Clin Psychiatry 54, 445–452

Kane, J M (1993) Newer antipsychotic drugs A review of their pharmacology and therapeutic potential Drugs 46, 585–593

Kane, J, Honigfeld, G, Singer, J, and Meltzer, H (1988) Clozapine for treatment-resistant schizophrenics A double-blind comparison with chlorpromazine Arch Gen Psychiat 45, 789–796

Kapur, S. and Remington, G (1996) Serotonin-dopamine interaction and its relevance to schizophrenia Am J Psychiat 153, 466–476

Keith, V A, Mansbach, R. S, and Geyer, M. A (1991) Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle Biol Psychiat 30, 557–566

Kinnard, W J and Carr, C J (1957) A preliminary procedure for the evaluation of central nervous system depressants J Pharmacol Exp Ther 121, 354–361

Kosten, T A and Nestler, E J (1994) Clozapine attenuates cocaine conditioned place preference Life Sci 55, 9–14

Kuribara, H. and Tadokoro, S. (1981) Correlation between antiavoidance activities of antipsychotic drugs in rats and daily clinical doses. Pharmacol Biochem Behav 14, 181–192

Kuschinsky, K and Hornykiewicz, O. (1972) Morphine catalepsy in the rat relation to striatal dopamine metabolism Eur J Pharmacol 19, 119–122

Landis, C and Hunt, W A (1939) The Startle Pattern Farrar and Rmehart, New York.

Lewander, T, Westerbergh, S. E, and Morrison, D. (1990) Clinical profile of remoxipride. a combined analysis of a comparative double-blind multicentre trial programme Acta Psychiat Scand 358, 92–98

Liebman, J. M (1983) Discrimination between reward and performance’ a critical review of intracranial self-stimulation methodology Neurosci. Biobeh Rev 7, 45–72

Liebman, J M (1989) Drug effects on behaviors maintained by electrical brain stimulation, in Neuromethods (vol 13) Psychopharmacology, (Boulton, A A, Baker, G B, and Greenshaw, A J, eds ), Humana, Clifton, NJ, pp 447–511

Liebmann, J M and Butcher, L L (1973) Effects of self-stimulation behaviour of drugs influencing dopaminergic neurotransmission mechanisms Naunyn Schmiedeberg’s Arch Pharmacol 227, 305–318.

Lipska, B K, Swerdlow, N R, Geyer, M A, Jaskiw, G E, Braff, D L, and Weinberger, D R (1995) Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes m prepulse inhibition of startle and its disruption by apomorphine Psychopharmacology 122, 35–43

Lister, R G. (1990) Ethologically-based animal models of anxiety disorders Pharmacol Ther 46, 321–340

Ljungberg, T (1990) Differential attenuation of water intake and water-rewarded operant responding by repeated administration of haloperidol and SCH 23390 in the rat Pharmacol Biochem Behav 35, 111–115

Ljungberg, T and Ungerstedt, U (1977) Apomorphine-induced locomotion and gnawing evidence that the experimental design greatly influences gnawing while locomotion remains unchanged Eur J Pharmacol 46, 147–151.

Ljungberg, T. and Ungerstedt, U (1978) Classification of neuroleptic drugs according to their ability to inhibit apomorphme-induced locomotion and gnawing evidence for two different mechanisms of action Psychopharmacology 56, 239–247

Mackey, W. B. and van der Kooy, D (1985) Neuroleptics block the positive reinforcing effects of amphetamine but not morphine as measured by place conditioning Pharmacol Biochem Behav 22, 101–105

Mansbach, R S. and Geyer, M A (1989) Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat Neuropsychopharmacology 2, 299–308

Mansbach, R. S, Geyer, M A, and Braff, D L. (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat Psychopharmacology 94, 507–514

Marder, S R and Meibach, R C (1994) Risperidone in the treatment of schizophrenia. Am J Psychiatry 151, 825–835

Martin, B. R, Prescott, W R, and Zhu, M. (1992) Quantitation of rodent catalepsy by a computer-imaging technique Pharmacol Biochem Behav 43, 381–386

Martm-Iverson, M T and McManus, D. J (1990) Stimulant conditioned locomotion is not affected by blockade of Dl and/or D2 dopamine receptors during conditioning Brain Res 521, 175–184

Mason, S T, Benmger, R J, Fibiger, H C, and Phillips, A G (1980) Pimozide-induced suppression of responding evidence against a block of food reward Pharmacol Biochem Behav 12, 917–923

Matz, R, Rick, W, Oh, D, Thompson, H, and Gershon, S (1975) Clozapine a potential antipsychotic agent without extrapyramidal manifestations Psychopharmacol Bull 11, 14

McCreadie, R. G (1992) A double-blind comparison of raclopnde and haloperidol in the acute phase of schizophrenia Acta Psychiatr Scand 86, 391–398

McGhie, A and Chapman, J (1961) Disorders of attention and perception m early schizophrenia Br J Med Psychol 34, 103–116

McGuire, M T and Polsky, R H (1980) Ethological assessment of stable and labile social behaviors during acute psychiatric disorders clinical applications Psychiatry Res 3, 291–296

McLean, J R, Parker, R B, and Coughenour, L L (1978) Effect of antipsychotic and other classes of drugs on spontaneous locomotor activity and neurotoxicity in mice Pharmacol Biochem Behav 8, 97–99

McQuade, R D, Duffy, R A, Coffin, V L, and Barnett, A (1992) In vivo bindmg to dopamine receptors a correlate of potential antipsychotic activity Eur J Pharmacol 215, 29–34

Meltzer, H Y, Matsubara, S, and Lee, J C (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine Dl, D2 and serotonin2 pK values. J Pharmacol Exp Ther 251, 238–246

Migler, B M, Warawa, E J, and Malick, J B (1993) Seroquel behavioral effects in conventional and novel tests for atypical antipsychotic drug Psychopharmacology 112, 299–307

Miller, R (1987) The time course of neuroleptic therapy for psychosis role of learning processes and implications for concepts of psychotic illness Psychopharmacology 92, 405–415

Minck, K, Danneberg, P, and Knappen, F. (1974) Effects of psychotropic drugs on exploratory behavior in mice Psychopharmacology 39, 245–257

Mithani, S, Martm-Iverson, M T, Phillips, A, G,, and Fibiger, H C (1986) The effects of haloperidol on amphetamine and methylphenidate-induced conditioned place preferences and locomotor activity Psychopharmacology 90, 247–252

Molloy, A G and Waddmgton, J L (1984) Dopaminergic behavior stereospecifically promoted by the Dl agonist R-SKF 38393 and selectively blocked by the Dl antagonist SCH 23390 Psychopharmacology 82, 409–410

Molloy, A G. and Waddmgton, J L (1985a) Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK & F 38393 and to apomorphine differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide Eur J Pharmacol 108, 305–308

Molloy, A G. and Waddmgton, J L (1985b) The enantiomers of SK&F 83566, a new selective D-1 dopamine antagonist, stereospecifically block stereotyped behavior induced by apomorphine and by the selective D-2 agonist RU 24213 Eur J Pharmacol 116, 183–186

Moore, N A, Tye, N C, Axton, M S, and Risius, F C (1992) The behavioral pharmacology of olanzapine, a novel “atypical” antipsychotic agent J Pharmacol Exp Ther 262, 545–551

Morency, M A and Beninger, R J (1987) Dopaminergic substrates of cocameinduced place conditioning Brain Res 399, 33–41

Murray, A M and Waddington J L (1990) The interaction of clozapine with dopamine Dl versus dopamine D2 receptor-mediated function behavioral indices Eur J Pharmacol 186, 79–86

Nakajima, S and Baker, J D (1989) Effects of D2 dopamine receptor blockade with raclopride on intracranial self-stimulation and food-reinforced operant behavior Psychopharmacology 98, 330–333

Needham, P L, Atkinson, J, Skill, M J and Heal, D J, (1996) Zotepine preclinical tests predict antipsychotic efficacy and an atypical profile Psychopharmacol Bull 32, 123–128

Niemegeers, C J E., Verbruggen, F J., and Janssen, P A J (1969) The influence of various neuroleptic drugs on shock avoidance responding in rats Psychopharmacology 16, 161–174

Nomikos, G G and Spyraki, C (1988) Effects of ritanserm on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats. Pharmacol Biochem Behav 30, 853–858

Ogren, S O and Archer, T (1994) Effects of typical and atypical antipsychotic drugs on two-way active avoidance Relationship to DA receptor blocking profile Psychopharmacology 114, 383–391

Ogren, S O, Florvall, L, Hall, H, Magnusson, O, and Angeby-Moller, K (1990) Neuropharmacological and behavioural properties of remoxipride in the rat Acta Psychiatr Scand 82(suppl. 358), 21–26

Ogren, S O, Hall, H, Kohler, C, Magnusson, O., and Sjostrand, S E (1986) The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions Psychopharmacology 90, 287–294

Ogren, S O, Hall, H, Kohler, C, Magnusson, O, Angeby-Moller, K, and Florvall, L. (1984) Remoxipride, a new potential antipsychotic compound with selective anti-dopaminergic actions in the rat brain Eur J Pharmacol 102, 459–474

Olds, J and Milner, P (1954) Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain J Camp Physiol Psychol 47, 419–427

Olds, M E (1976) Effectiveness of morphine and ineffectiveness of diazepam and phenobarbital on the motivational properties of hypothalamic self-stimulation behavior Neuropharmacology 15, 117–131

Olney, J. W. and Farber, N B (1995) NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins and research tools for studying schizophrenia. Neuropsychopharmacology 13, 335–345

Padich, R. A, McCloskey, T C, Hitchcock, J M. and Kehne, J H (1993) Effects of the selective 5-HT2 antagonist MDL 100, 907 on fenfluramine-, MDMA-, or DOI-induced disruption of auditory or visual prepulse inhibition in rats. Soc. Neurosci Abstr 19, 666.12

Papp, M. (1988) Different effects of short-and long-term treatment with imipramine on the apomorphine-and food-induced place preference conditioning in rats Pharmacol Biochem Behav 30, 889–893.

Fellow, S, Chopin, P, File, S E, and Bnley, M. (1985) Validation of open closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J Neurosci Methods 14, 149–167

Peng, R Y, Mansbach, R S, and Braff, D L (1990) A D2 dopamime receptor agonist disrupts sensorimotor gating in rats implications for dopaminergic abnormalities in schizophrenia Neuropsychopharmacology 3, 211–218

Petit, M, Raniwalla, J, Lutteneger, E, Tweed, J A, and Kelly, R. (1996) A comparison of an atypical and typical antipsychotic zotepine versus haloperidol in patients with acute exacerbation of schizophrenia Psychopharmacol Bull 32, 81–87

Pettit, H O, Batsell, W R, Jr, and Mueller, K (1989) Triazolam attenuates amphetamine but not morphine conditioned place preferences Psychopharmacology 98, 483–486

Pickar, D, Owen, R R, Litman, R E, Konicki, E, Gutierrez, R, and Rapaport, M H (1992) Clinical and biologic response to clozapine in patients with schizophrenia Crossover comparison with fluphenazine Arch Gen Psychiat 49, 345–353

Potkin, S G, Costa, J, Roy, W, Sramek, J, Jin, Y, and Gulasekaram, B (1992) Glycine in the treatment of schizophrenia Theory and preliminary results, in Novel Antipsychotic Drugs, (Meltzer, H Y, ed ), Raven, New York, pp.179–188

Prissen, E P M, Ellenbroek, B A, Stamatovic, B, and Cools, A R (1993) The effects of haloperidol and raclopnde in the paw test are influenced similarly by SCH 39166 Eur J Pharmacol 231, 275–280

Puech, A J, Simon, P, and Bossier, J R (1976) Antagonism by sulpiride of three apomorphine-induced effects m rodents Eur J Pharmacol 36, 439–441

Pycock, C, Tarsy, D, and Marsden, C D (1975) Inhibition of circhng behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum Psychopharmacology 45, 211–219

Quitkin, F., Rifkm, A, and Klein, D F (1975) Very high dosage vs standard dosage fluphenazine in schizophrenia A double-blind study of nonchronic treatment-refractory patients Arch Gen Psychiat 32, 1276–1281

Rigdon, G C and Vuk, K (1991) Prepulse inhibition as a screening test for potential antipsychotics Drug Dev Res 23, 91–99

Robbins, T W. (1977) A critique of the methods available for the measurement of spontaneous motor activity, in Handbook of Psychopharmacology, (vol. 7), (Iversen, L L, Iversen, S D, and Snyder, S H, eds), Plenum, New York, pp 37–82

Sanberg, P R., Bunsey, M D., Giordano, M, and Norman, A B (1988) The catalepsy test its ups and downs Behav Neurosci 102, 748–759

Sanger, D J (1985) The effects of clozapine on shuttle-box avoidance responding in rats comparisons with haloperidol and chlordiazepoxide Pharmacol Biochem Behav 23, 231–236

Sanger, D J (1986) Response decrement patterns after neuroleptic and non-neuroleptic drugs Psychopharmacology 89, 98–104

Schechter, M D. and Calcagnetti, D J (1993) Trends in place preference conditioning with a cross-indexed bibliography 1975-1991 Neurosci Biobehav Rev 17, 21–41

Scheel-Kruger, J., Arnt, J, Braestrup, C, Christensen, A. V, and Magelund, C (1979) Development of new animal models for GABAergic actions using muscimol as a tool, in GABA-Neurotransmitters, (Krogsgaard-Larsen, P, Scheel-Kruger, J, and Kofod, H, eds ), Munksgaard, Copenhagen, pp 447–464

Seeman, P (1980) Brain dopamine receptors Pharmacol Rev 32, 229–313

Shopsin, B, Klein, H, Aronson, M, and Collora, M (1979) Clozapine, chlorpromazine and placebo in newly hospitalized acutely schizophrenic patients Arch Gen Psychtat 36, 657–664

Shropshire, A T and Marquis, K L (1991) Evaluating the paw test as a paradigm for differentiating between classical and atypical neuroleptics Soc Neurosci Abstr 17, 686

Simons, R F. and Giardina, B D (1992) Reflex modification in psychosis-prone young adults. Psychophyswlogy 29, 8–16.

Sipes, T A. and Geyer, M A. (1994) 8-OHDPAT disruption of prepulse inhibition in rats reversal with (+)WAY 100, 135 and localization of the site of action Psychopharmacology 117, 41–48.

Spyraki, C, Fibiger, H C, and Phillips, A G. (1982a) Dopaminergic substrates of amphetamine-induced place preference conditioning Brain Res 253, 185–193

Spyraki, C, Fibiger, H C, and Phillips, A G (1982b) Attenuation by haloperidol of place preference conditioning using food reinforcement Psychopharmacology 77, 379–382

Stille, G, Lauener, H., and Eichenberger, E (1971) The pharmacology of 8-chloroll(4-methyl-l-piperazinyl)-5-h-dibenzo [b, e] [1, 4] diazepine )clozapine) II Tarnaco 26, 603–624.

Svensson, A, Carls&on, M L, and Carlsson, A (1992) Interaction between glutamatergic and dopaminergic tone in the nucleus accumbens of mice evidence for a dual glutamatergic function with psychomotor control J Neural Trans 99, 235–240

Swerdlow, N R and Geyer, M A (1993) Clozapine and halopendol in an animal model of sensorimotor gating deficits in schizophrenia Pharmacol Biochem Behav 44, 741–744

Swerdlow, N. R., Braff, D L, Masten, V L, and Geyer, M. A (1990) Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens Psychopharmacology 101, 414–420

Swerdlow, N R, Braff, D L, Taaid, N, and Geyer, M A (1994) Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients Arch Gen Psychtat 51, 139–154

Swerdlow, N R, Came, B, and Geyer, M. A. (1991) Opiate-dopamine interactions in the neural substrate of acoustic startle gating in the rat Prog Neuropsychol Bio Psychtat 15, 514–526

Swerdlow, N R., Geyer, M, Braff, D, and Koob, G F (1986) Central dopamine hyperactivity in rats mimics abnormal acoustic startle in schizophrenics. Biol Psychiat 21, 23–33

Swerdlow, N R., Keith, V A, Braff, D. L., and Geyer, M. A. (1991) Effects of spiperone, raclopnde, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat J Pharmacol Exp. Ther 256, 530–536

Swerdlow, N. R, Lipska, B K, Weinberger, D R, Braff, B L., Jaskiw, G E., and Geyer, M A (1995) Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats Psychopharmacology 122, 27–34

Swerdlow, N R., Mansbach, R S, Geyer, M A, Pulvirenti, L, Koob, G F, and Braff, D L (1990) Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine Psychopharmacology 100, 413–416

Swerdlow, N R, Mansbach, R S, Geyer, M A, Pulvirent, L, Koob, G F, and Brail, D L (1990) Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine Psychopharmacology 100, 413–420

Szczepanik, A M, Brougham, L R, Roehr, J E, Conway, P G, Ellis, D B, and Wilmot, C A (1996) Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity J Pharmacol Exp Ther 278, 913–920

Treit, D (1985) Animal models for the study of anti-anxiety agents a review Neurosci Btobehav Rev 9, 203–222

Turski, L, Havemann, U, and Kuschinsky, K (1982) Evidence for functional interactions of morphine in substantia nigra and striatum in relation to muscular rigidity m rats Neurosci Lett 28, 291–293

Tzschentke, T M and Schmidt, W. J (1996) Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist Eur J Pharmacol 295, 137–146

Undie, A S and Friedman, E (1988) Differences in the cataleptogenic actions of SCH 23390 and selected classical neuroleptics Psychopharmacology 96, 311–316

Ungerstedt, U (1971a) Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behavior Acta Phystol Scand 82(suppl 367), 49–68

Ungertstedt, U (1971b) Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system Acta Physiol Scand 82(suppl. 367), 69–93

Varty, G B and Higgins, G A (1994) Differences between three rats strains in sensitivity to prepulse inhibition of an acoustic startle response influence of apomorphine and phencyclidine pretreatment J Psychopharmacol 8, 148–156

Varty, G B and Higgins, G A (1995) Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs Psychopharmacology 122, 15–26

Wadenberg, M L (1992) Antagonism of 8-OH-DPAT, but not ntanserin, of catalepsy induced by SCH 23390 in the rat J Neural Transm 89, 49–59

Wan, F J and Swerdlow, N R (1994) Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats Psychopharmacology 113, 103–109

Wauquier, A (1979) Neuroleptics and brain self-stimulation behavior Int Rev Neurobiol 21, 335–403

Wauquier, A and Niemegeers, C J E (1972) Intracranial self-stimulation in rats as a function of various stimulus parameters II Influence of haloperidol, pimozide and pipamperone on medial forebrain stimulation with monopolar electrodes. Psychopharmacologta 27, 191–202

Wedzony, K., Golembiowska, K., and Azaula, M (1994) Differential effects of CGP 37849 and MK-801, competitive and non-competitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats Naunyn-Schmiedeberg’s Arch Pharmacol 350, 555–562

Weinberger, D R (1987) Implications of normal brain development for the pathogenesis of schizophrenia Arch Gen Psychiat 44, 660–669

Weinberger, D R, Berman, K F, and Zee, R F (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia I Regional cerebral blood flow evidence Arch Gen Psych 43, 114–124

Wenger, G R (1979) Effects of clozapine, chlorpromazine and haloperidol on schedule-controlled behavior Pharmacol Bwchem Behav 11, 661–667

Wetzel, H, Szegedi, A, Hain, C, Wiesner, J., Schlegel, S, and Benkert, O (1995) Seroquel (ICI 204 636), a putative “atypical” antipsychotic, in schizophrenia with positive symptomatology results of an open clinical trial and changes of neuroendorinological and EEG parameters Psychopharmacol 119, 231–238

White, I M, Ciancone, M T, Haracz, J. L and Rebec, G V. (1991) A lever-release version of the conditioned avoidance response paradigm effects of haloperidol, clozapine, sulpiride, and BMY-148–2 Pharmacol Bwchem Behav 41, 29–35

Wise, R A (1978) Neuroleptic attenuation of intracranial self-stimulation reward or performance deficits’ Life Sci 22, 535–542

Wise, R A (1982) Neuroleptics and operant behavior the anhedonia hypothesis Behav Brum Sci 5, 39–53

Wise, R A, Spindler, J, de Wit, H, and Gerber, J G (1978) Neuroleptic induced “anhedonia” in rats pimozide blocks reward quality of food Science 201, 262–264

Worms, P and Lloyd, K G (1979) Predictability and specificity of behavioral screening tests for neuroleptics Pharmac Ther 5, 445–450

Worms, P, Broekkamp, CLE, and Lloyd, K G (1983) Behavioral effects of neuroleptics, in Neuroleptics Neurochemical, Behavioral and Clinical Perspectives (Coyle, J T, and Enna, S J, eds ), New York, Raven, pp 93–117

Wu, J C, Potkin, S G., Ploszaj, D I, Lau, V, Telford, G and Richmond, G (1992) Clozapine improves sensory gating more than haldol APA Abstr 156

Zarevics, P, Weidley, E, and Setler, P (1977) Blockade of intracranial self-stimulation by antipsychotic drugs failure to correlate with central alpha-noradrenergic blockade Psychopharmacology 53, 283–288

Zebrowska-Lupma, J (1977) The effect of a-adrenolytics on central actions of agonists and antagonists of dopaminergic system Pol J Pharmacol 29, 393–404

Comments (Loading...)

Post comment/View all comments